nurown

Cell therapyexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Feb 28, 2019 (NCT03799718)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • NeuronsTissue restoration

    tissue restoration - neurons

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06973629Phase 3Jun 30, 2025Brainstorm Cell Therapeutics
NCT03799718Phase 2Feb 28, 2019Brainstorm Cell Therapeutics, The Cleveland Clinic
NCT04681118N/ABrainstorm Cell Therapeutics
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Brainstorm Cell TherapeuticsFor profit3332019
The Cleveland ClinicAcademic/Hospital1012019
2 organizations
Page 1 / 1